Abstract. To evaluate the role of N-linked oligosaccharides in the molecular action of rat placental lactogen (PL), recombinant PL-Im (recPL-Im) and three recPL-Im mutants were produced in COS-7 cells. The mutants, carrying Gin substitutions of Asn at putative N glycosylation sites, were generated via sitedirected mutagenesis, i.e. two single mutants (N79Q, N128Q) and one double mutant (N79Q/N128Q). Western blot analysis revealed that wild type recPL-Im had a molecular mass of 34 kDa , which was reduced to 29 kDa by tunicamycin present during expression. N79Q and N128Q had a lower molecular mass than the wild type, and a further decrease was observed for N79Q/N128Q. PL-Im was therefore N-glycosylated at both Asn79 and Asn128. Treatment of the wild type with neuraminidase caused a reduction in molecular mass, indicating that the N-linked oligosaccharides contained Nacetylneuraminic acids. In the Nb2 cell bioassay for lactogenic hormones, recPL-Im and its mutants all had growth-promoting activity but there was a decline in the growth-stimulating potency following decreases in N-glycosylation, i.e. the order of relative potencies was the wild type>N128Q> N79Q>N79Q/N128Q, suggesting that the N-linked oligosaccharides are important in the mitogenic action of the PL-Im. Wild type and all mutants had rat PRL receptor (PRL-R)-binding activity in radioreceptor assays and stimulated JAK2 phosphorylation in Nb2 cells. Interestingly however, the binding activity to PRL-R and phosphorylation of JAK2 was similar in the wild type and mutants, and these results are not in accord with the biological activity. In conclusion, the study suggested that PL-Im has two N-linked oligosaccharides which are involved in its biological activity. The ability of PL-Im to bind PRL-R and activate JAK2 appears to be independent of the N glycosylation.
[11], PLP-C related protein [121 and PLP-C variant [13] . Recently, it was suggested that PL-Im is identical to PL-I based on the observation that the originally identified PL-I, as distinct from PL-Im, could not be isolated from the cDNA libraries of Rcho-1 cells and midgestation placental tissue, or from a rat genomic library [14] . Thus, the structure of PL-Im is closely related to that of PL-I and they are the only PLs expressed at midpregnancy.
It is still unclear, however, whether PL-Im and PL-I are identical proteins. Proteins of the placental PRL family are grouped according to their ability to bind the PRL receptor (PRL-R). Whereas PL-I, PL-II, PL-Iv and PL-Im can bind to the PRL-R [15] [16] [17] , the other PLPs apparently cannot [18] [19] [20] [21] . With the exception of PL-II, all members of the placental PRL family have one or two putative Nglycosylation sites, asparagine-Xaa-serine/ threonine (Asn Xaa-Ser/Thr), where Xaa can be any amino acid except for proline. PL-Im has two putative N-glycosylation sites at Asn79 and Asn128 [16] .
It is known that the oligosaccharide of a glycoprotein contributes to the physicochemical characteristics of the protein, including hydrophilicity, electric charge, resistance to proteases, and pH and temperature stability [22] [23] [24] [25] [26] . N-linked oligosaccharides of pituitary or placental glycoprotein hormones, such as FSH [27, 28] and human and equine chorionic gonadotropin (CG) [29] [30] [31] , are crucial to biological activities. Some of the oligosaccharides affect the heterodimerization of the subunits [30, 32] , and others take part in ligand-receptor signal transduction.
Recently, we reported that N-and O -linked oligosaccharides of equine CG are involved in the switching of its biological activity from FSH-like to LH-like activities [31] .
Oligosaccharide moieties, therefore, can affect the secretion, folding and function of the protein hormone.
Nb2 lymphoma cell cultures, which were established by Gout et al. [33] , can be used in a sensitive in vitro bioassay system to determine the mitogenic activities of lactogenic hormones, including PRL, PL and primate GH [34] . The assay is also useful for the analysis of structure-function relationships of lactogenic hormones [35] . The proliferative activities of lactogenic hormones for Nb2 cells are mediated by cell surface PRL-R [36] .
JAK2 forms a complex with the cytoplasmic region of PRL-R before signaling, and is phosphorylated rapidly after stimulus by PRL [37] [38] [39] . Phosphorylation of STATs has been reported to occur downstream of JAK2 activation [40, 41] . Phosphorylation of JAK2 seems to be an early stage of PRL signaling.
The members of PRL/GH/placental PRL superfamily have conserved cysteine residues for disulfide bonds and are considered to have similar tertiary structures [42] . To date, the three dimensional (3-D) structures of porcine and human GH have been determined by X-ray diffraction [43] [44] [45] [46] , and can be used as template structures for predicting the 3-D structures of the members of the PRL/GH/placental PRL superfamily. A 3-D structural model of the placental PRL family with N-linked oligosaccharides may help clarify the effects of N-glycosylation, at least on receptor binding.
The present study utilized site-directed mutagenesis to determine whether PL-Im has Nlinked oligosaccharides, and if so, where and how many oligosaccharides are attached to PL-Im, and whether the oligosaccharides are involved in its mitogenic activity. The bioactivities of recombinant PL-Im produced in COS-7 cells and PL-Im mutants carrying modified putative N-glycosylation sites were evaluated in rat Nb2 lymphoma cell cultures and their PRL-R binding activities were measured by radioreceptor assay (RRA). We also constructed a 3-D model of the glycosylated PL-Im by computer simulation based on its structural similarity to hGH [45] , and evaluated the relationship between the two N-glycosylation sites and the binding sites of PL-Im to PRL-R.
Materials and Methods

Reagents
Restriction enzymes, ligase for vector construction and reagents for site-directed mutagenesis were purchased from TAKARA SHUZO (Shiga, Japan). DMEM was from GIBCO BRL (Grand Island, NY, U. S. A.). FCS was obtained from JRH Biosciences (Lenexa, KS, U. S. A.). Donor horse serum (HS) was from Summit Biotechnology (Ft. Collins, CO, U. S. A.). A colorimetric "Cell Counting Kit" with WST-1 was purchased from Dojin Chemical (Kumamoto, Japan).
Peptide N-glycosidase F (PNGase F: NGlycanase) was purchased from Genzyme (Cambridge, MA, U. S. A. . oPRL was first dissolved in 0.03 M NaHCO3, 0.15 M NaC1 (pH 10.8) and then the pH was adjusted to 8.5 by drop-wise addition of 2 N HC1. Antiphosphotyrosine antibody conjugated to agarose was purchased from Transduction Laboratories (Lexington, KY, U. S. A.) and anti-JAK2 antiserum from Upstate Biotechnology (Lake Placid, NY, U. S. A.). Other reagents were purchased from Wako Pure Chemicals (Osaka, Japan).
Site-directed mutagenesis of PL-Im
Four recombinant proteins (Wild type, N79Q, N128Q and N79Q/N128(2) were prepared (Fig.  1A) . Asparagine79 (Asn79) was replaced with glutamine (Gln) in N79Q, Asn128 was replaced with Gln in N128Q, and both substitutions were present in N79Q/N128Q.
The site-directed mutagenesis of PL-Im was carried out by Kunkel's method [47, 48] with the full length PL-Im cDNA, pUC-PL-Im, isolated in our laboratory [1] . To remove the N-glycosylation sites, we designed oligonucleotides to replace Asn with Gln in the consensus sequences of PL-Im. Similar substitutions have previously been used for the production of deglycosylated mutants of hCG [49] and erythropoietin [50, 51] 
Results
Expression of recombinant PL-Im and its mutants COS-7 cells, transfected with wild type expression vector, were cultured for 6 days and the conditioned medium was subjected to analysis by Western blotting. Recombinant PL-Im with a molecular mass of about 34 kDa was found to be present in the conditioned medium (Fig 2A, lane  1 3, 5 and 7 ) and the cell lysates (lanes 2, 4, 6 and 8) were prepared at day 5 of culturing and the mobilities of wild type (lanes 1 and 2) and three mutants, N79Q (lanes 3 and 4), N128Q (lanes 5 and 6) and N79Q/N128Q
(lanes 7 and 8) were determined.
(C) Conditioned media of wild type (lanes 1 and 2), N79Q (lanes 3 and 4), N128Q (lanes 5 and 6) and N79Q/N128Q
(lanes 7 and 8) were prepared and analyzed. To confirm the state of Nglycosylation in recPL-Im, tunicamycin was added to the culture media (lanes 2, 4, 6 and 8).
contains sialilated oligosaccharides. The molecular mass was also decreased after PNGase F treatment, which cleaves the glycosylamine linkage and releases the N-linked oligosaccharide from the peptide. The molecular weight of this deglycosylated recPL-Im was about 29 kDa (Fig.  2A, lane 3) .
All three mutants (N79Q, N128Q and N79Q/ N128Q) had lower molecular masses than the wild type protein (Fig. 2B, lanes 1, 3, 5 and 7) . The N79Q protein was approximately 32 kDa, and N128Q was about 31 kDa, which was slightly smaller than N79Q. This indicates that both of the putative glycosylation sites (Asn79, Asn128) in PLIm are glycosylated. The molecular mass of the double mutant N79Q/N128Q was 29 kDa, the same value as obtained for the wild type following the treatment with PNGase F and smaller than that found for N79Q and N79Q/N128Q. Western blot analysis of cell lysates on day 5 revealed that intracellular accumulation of the wild type and the mutants did not occur (Fig 2B, lanes 2, 4, 6 and 8 ).
To investigate whether the different molecular masses of the mutants were caused by the removal of N-linked oligosaccharides, COS-7 cells were treated with tunicamycin during the expression of the recombinant proteins (Fig. 2C) . As a result of this treatment, the molecular mass of wild type protein became 29 kDa, confirming the results of the experiments with PNGase F. All mutant proteins expressed in the presence of tunicamycin also had a 29 kDa size, indicating that the changes in molecular mass resulted not from the nonspecific peptide changes by mutation, such as the cleavage, but from the oligosaccharides removal.
Quantification of recPL-Im by ELISA
We used two antipeptide antibodies to evaluate the amount of recPL-Ims in the conditioned media. In this ELISA system, we could measure the wild type recPL-Ims treated with or without PNGase F equally (data not shown).
The amount of recombinant PL-Im in culture medium was measured by ELISA with two antipeptide antisera to rat PL-I. The standard curve indicated that the measurable range of PL-Im with this ELISA was 5-100 ng/ml (Fig. 3A) . The dilution-absorbance curves of the wild type and the mutants are also shown in Fig. 3A was valid for the evaluation of the wild type recPLIm as well as its mutants. Figure 3B shows the amount of each recombinant protein in the culture medium at 24 h intervals. In each case, the amount of protein increased at a constant rate up to 5 days after transfection, and had noticeably decreased at day 6. Relative to the wild type and single mutants (N79Q and N128Q), the N79Q/N128Q double mutant had lower amounts, particularly on days 5 and 6 (P<0.05). 
Discussion
By site-directed mutagenesis, the present study has indicated that recombinant PL-Im has two Nlinked oligosaccharides at Asn79 and Asn128, and that these oligosaccharides participate in the mitogenic action of PL-Im. Treatment of recPL-Im with PNGase F, which cleaves N-linked oligosaccharides from the peptide, caused a reduction in molecular mass from 34 to 29 kDa. The reduced size was identical to that of the recombinant proteins produced in the presence of tunicamycin, indicating that the total size of Nlinked oligosaccharides attached to the recPL-Im is approximately 5 kDa. Based on the molecular masses of N79Q, N128Q and N79Q/N128Q, Nlinked oligosaccharides at Asn79 and Asn128 of recPL-Im are thought to be distinct structures and were estimated to amount to 2 and 3 kDa, respectively. Since treatment of recPL-Im with neuraminidase decreased its molecular mass, the oligosaccharide of recPL-Im seems to contain NeuAcs.
Based on these results, the oligosaccharides attached at both sites are likely to consist of 10-15 monosaccharides including NeuAc. The present study clearly demonstrated that the recPL-Im has a mitogenic action on the Nb2 lymphoma cells: ability to bind to PRL-R and to phosphorylate JAK2 in Nb2 cells. Interestingly, the Nb2 mitogenic activity of the wild type recPLIm was greater than that of oPRL, although its binding affinity for PRL-R was lower than that of oPRL.
PRL-Rs belong to the cytokine/ hematopoietin receptor superfamily, whose members lack the intrinsic tyrosine kinase in their cytoplasmic regions [65, 66] . JAK2 is pre-associated with the cytoplasmic domain of the PRL-R before the signaling and is phosphorylated rapidly after dimerization of the receptors [37] [38] [39] . glycosylated mutant of PL-Im (N79Q/N128Q), which had the least biological potency among all the recombinants, showed similar potency to oPRL in the Nb2 cell proliferation assay. In this mutant, however, the receptor binding affinity was less than that of oPRL, but its ability to phosphorylate JAK2 exceeded that of oPRL. Therefore, the mechanisms by which the mutant PL and oPRL promote Nb2 cell proliferation appear to be qualitatively different.
Elimination of the N-glycosylation sites from recPL-Im decreased its biological activity, and the relative potencies in Nb2 proliferation assay were wild type>N128Q>N79Q>N79Q/N128Q. Therefore, the oligosaccharide moieties of recPLIm may be involved in the mitogenic signaling mechanism.
The PRL-R binding and JAK2
phosphorylation activities of the PL-Im mutants, however, are similar to that of the wild type, and therefore the decreased activities in the mutants in Nb2 cell proliferation assay cannot be explained by differences in the levels of the receptor binding and phosphorylation of JAK2. Other members of the cytokine superfamily, including granulocytemacrophage colony-stimulating factor and erythropoietin, have been reported to use another signal transduction system involving Ras-MAP kinase besides the JAK/STAT pathway [67, 68] . In these cytokines, N-linked oligosaccharides are known to be important regulators of their biological activities [69] [70] [71] . Recently, PRL signaling was also reported to activate components of the Ras-MAP kinase pathway [72] [73] [74] . Oligosaccharides attached to recPL-Im may therefore be involved in signal transducing systems other than JAK2/STAT, considering the N-glycosylation sites in the tertiary structure model of PL-Im and the experimental results indicating that oligosaccharides do not directly interfere with binding to the PRL-R. Removal of N-linked oligosaccharides may cause a change in the tertiary structure of the whole molecule, or a change in the conformation and the spatial position of the side chains of the amino acids relevant to the biological activity and the binding of the PL-Im to two receptors.
The fact that the biological potencies did not parallel PRL-R binding affinity in the recombinant PL-Im proteins raises the possibility that recPL-Im may also stimulate the proliferation of Nb2 cells through another receptor system. This system may include a heterodimer or oligomer receptor complex consisting of unidentified receptor molecules or an authentic one, such as gp130, employed by other cytokines.
For example, leukemia inhibitory factor (LIF) is reported to act through a heterodimer receptor complex composed of LIF receptor and gp130, and IL-6 through a complex of IL-6 receptor alpha and two gp130 molecules. Recently, a novel candidate molecule involved in the PRL signaling, PRL-R associated protein (PRAP), has been reported [75] . PRAP was associated with the short form of the PRL-R specifically and phosphorylated in response to stimulation by PRL. Nb2 cells may have the short form of the PRL-R as well as the long and Nb2 forms [72, 76, 77] . Although both oligosaccharide moieties of PL-Im (at Asn79 and Asn128) are involved in its biological activity, they seem to occupy the space located opposite to the PRL-R binding sites of the hormone.
The series of PL-Im mutant molecules will be unique tools for analyzing the cellular mechanisms involved in the signal transduction of lactogens with functional oligosaccharides.
Intracellular accumulation of the recombinant proteins was relatively low and did not differ between wild type and mutant proteins, while the amount of recombinant PL-Im in the culture medium varied depending on the type of mutant. In case of the double mutant (N79Q/N128Q), the amount of protein secreted was significantly lower than that of the wild type or the single mutants (N79Q or N128Q). Since intracellular contents were similar in all the mutants, the total amount was thought to be lower for the double mutant. These results were reproducible in three independent experiments in which we used the same amount of expression vector for each mutant. Similar phenomena have been reported in non-glycosylated mutants of human renin and erythropoietin [50, 78] 
